英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

callback    
n. 收回

收回

callback
n 1: a request by the manufacturer of a defective product to
return the product (as for replacement or repair) [synonym:
{recall}, {callback}]

call-back \call-back\ n.
1. a return call, especially a telephone call.
[WordNet 1.5]

2. the recall of an employee to work after a layoff.
[WordNet 1.5]

1. A scheme used in {event-driven} programs
where the program registers a {subroutine} (a "callback
handler") to handle a certain {event}. The program does not
call the handler directly but when the event occurs, the
{run-time system} calls the handler, usually passing it
arguments to describe the event.

2. A {user authentication} scheme
used by some computers running {dial-up} services. The user
dials in to the computer and gives his {user name} and
{password}. The computer then hangs up the connection and
uses an {auto-dial} {modem} to call back to the user's
registered telephone number. Thus, if an unauthorised person
discovers a user's password, the callback will go, not to him,
but to the owner of that login who will then know that his
account is under attack.

However, some {PABXs} can be fooled into thinking that the
caller has hung up by sending them a dial tone. When the
computer tries to call out on the same line it is not actually
dialing through to the authorised user but is still connected
to the original caller.

3. {cost control callback}.

(2003-07-13)


请选择你想看的字典辞典：
单词字典翻译
callback查看　callback　在百度字典中的解释百度英翻中〔查看〕
callback查看　callback　在Google字典中的解释Google英翻中〔查看〕
callback查看　callback　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Living Guidelines - ESMO
    ESMO Living Guidelines: Your dynamic resource for staying ahead in the fast-evolving fields of oncology These continuously updated guidelines cover rapidly changing topics, offering all the recommendations and algorithms from the ESMO Clinical Practice Guidelines Presented in an interactive format, they include direct links to MCBS scorecards and journal references, empowering clinicians
  • ESMO Clinical Practice Guideline: Non-Oncogene-Addicted Metastatic Non . . .
    ESMO is a Swiss-registered not-for-profit organisation All funding for this site is provided directly by ESMO Via Ginevra 4, 6900 Lugano - CH
  • EN | Non-Small-Cell Lung Cancer: Guide for Patients
    Non-small-cell lung cancer (NSCLC) An ESMO guide for patients Patient information based on ESMO Clinical Practice Guidelines This guide has been prepared to help you, as well as your friends, family and caregivers, better understand non-small-cell lung cancer (NSCLC) and its treatment
  • A Combination of Savolitinib and Osimertinib Prolongs PFS in Patients . . .
    In a multicentre, randomised, active-controlled, open-label, phase III SACHI study, a combination treatment with savolitinib and osimertinib improved progression-free survival (PFS) versus chemotherapy in patients with EGFR -mutated, MET -amplified non-small-cell lung cancer (NSCLC) that had progressed on EGFR tyrosine kinase inhibitor (TKI) therapy, while maintaining a favourable tolerability
  • ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
    In 2023, the ESCAT scores were included in treatment recommendations for oncogene-addicted metastatic non-small cell lung cancer , epithelial ovarian cancer , pancreatic cancer , and early breast cancer
  • ESMO Clinical Practice Guideline: Advanced and Metastatic Prostate Cancer
    Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Ann Oncol 2026;37 (5):590-607 Fizazi K, Attard G, Azad AA, et al , on behalf of the ESMO Guidelines Committee This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing advanced prostate cancer The guideline covers diagnosis, treatment and
  • Taletrectinib Demonstrates Durable Long-Term Efficacy in Both TKI-naïve . . .
    With extended follow-up in a phase II, multicentre, open-label, single-arm TRUST-I study, taletrectinib continued to demonstrate durable responses in both tyrosine kinase inhibitor (TKI)-naïve and crizotinib-pretreated patients with advanced ROS1 -positive non-small cell lung cancer (NSCLC), including intracranial activity and efficacy against the ROS1 G2032R resistance mutation The median
  • EMA Recommends Extension of Indications for Serplulimab
    Oesophageal squamous cell carcinoma Hetronifly in combination with fluoropyrimidine- and platinum-based chemotherapy is indicated for the first-line treatment of adult patients with unresectable, locally advanced, recurrent or metastatic oesophageal squamous cell carcinoma whose tumours express PD-L1 with a combined positive score ≥ 5
  • Similar Efficacy Between Subcutaneous and Intravenous Pembrolizumab . . .
    Login to your ESMO Accountto sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits
  • FDA Approves Osimertinib with Platinum-Based Chemotherapy for . . . - ESMO
    ESMO is a Swiss-registered not-for-profit organisation All funding for this site is provided directly by ESMO Via Ginevra 4, 6900 Lugano - CH





中文字典-英文字典  2005-2009